Age-related Macular Degeneration

On September 21-22, 2012, Harvard Ophthalmology hosted its 2nd Biennial International Symposium on age-related macular degeneration (AMD), which spurred lively discussion and debate among more than 200 clinicians, researchers, and trainees in attendance...

Drawing nearly 250 clinicians, researchers, trainees, and industry representatives from around the world, the Third International Biennial Symposium on AMD, which was held October 24–25, 2014 and co-chaired by Chief and Chair of Ophthalmology, Joan Miller...

A diverse and distinguished group of clinicians and researchers from around the world enjoyed a stimulating two days of active discussion at the first international AMD symposium hosted by the Harvard Ophthalmology. The symposium, which also included...

A phase I/II clinical trial at Massachusetts Eye and Ear found that some patients taking high doses of atorvastatin (cholesterol-lowering medication) had complete resolution of lipid deposits in the dry form of age-related macular degeneration (AMD). AMD...